Address |
60 Jubilee Avenue Abingdon Oxfordshire OX14 4RX United Kingdom |
Employees | - |
Website | http://adaptimmune.com |
Updated | 07/08/2019 |
Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. |